Canadian Sec - Delayed Quote CAD
Onco-Innova (ONCO.CN)
1.4500
+0.0300
+(2.11%)
At close: 3:59:30 PM EDT
Breakdown
TTM
4/30/2024
4/30/2023
Operating Cash Flow
-6.2990
-6.2990
-0.2330
Financing Cash Flow
80
80
18.7500
End Cash Position
92.2180
92.2180
18.5170
Issuance of Capital Stock
80
80
18.7500
Free Cash Flow
-6.2990
-6.2990
-0.2330
4/30/2023 - 11/27/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASEP.CN ASEP Medical Holdings Inc.
0.5000
0.00%
REGN.VI Regeneron Pharmaceuticals, Inc.
523.80
+0.77%
BCT.TO BriaCell Therapeutics Corp.
8.45
+18.68%
KZR Kezar Life Sciences, Inc.
4.7500
+3.71%
TLX Telix Pharmaceuticals Limited
19.22
+5.03%
ONCO Onconetix, Inc.
0.0690
+3.45%
TH.TO Theratechnologies Inc.
3.9100
+3.17%
NKTX Nkarta, Inc.
2.2000
+0.92%
ALDX Aldeyra Therapeutics, Inc.
2.6500
+9.50%
ABEO Abeona Therapeutics Inc.
5.39
+3.26%